Asymptomatic bacteriuria in pregnancy
Open Access
- 8 May 2023
- journal article
- research article
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 63 (5) , 696-701
Abstract
Background: Asymptomatic bacteriuria (ASB) is associated with adverse maternal and neonatal outcomes and is routinely screened for and treated in the first trimester. Prevalence of ASB in the second and third trimesters of pregnancy is unknown.Aims: The aim is to determine the prevalence of ASB in the second and third trimesters of pregnancy.Methods: Prospective cohort study of 150 pregnant women. Mid‐stream urine samples were tested for ASB in the second (24–28+6) and third (32–36+6) trimesters. Women were assigned to one of two groups: (i) ASB in any trimester of pregnancy and (ii) no evidence of ASB in pregnancy. Maternal and neonatal outcomes were compared between groups.Results: Among 143 women included in the study, the rate of ASB was 4.9% (2.1, 2.1 and 3.2% in the first, second and third trimesters, respectively). Of those with ASB, 14% had it in every trimester, whereas 43% had it on two or more samples. Of those with ASB in pregnancy, 43% were detected for the first time in the third trimester. Rates of maternal and neonatal outcomes were not statistically significantly different between the two groups. No women with ASB were induced for chorioamnionitis or growth restriction.Conclusion: The rate of ASB was highest in the third trimester of pregnancy, with rates of 2.1, 2.1 and 3.2% in the first, second and third trimesters, respectively. This study was underpowered to assess maternal and fetal outcomes. Although numbers were small, the absence of ASB in the first trimester was a poor predictor of ASB in the third trimester.Keywords
Funding Information
- RANZCOG Research Foundation
This publication has 16 references indexed in Scilit:
- Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trialThe Lancet Infectious Diseases, 2015
- Urinary tract infection in gynaecology and obstetricsObstetrics, Gynaecology & Reproductive Medicine, 2014
- Bacteruria with group-B streptococcus: is it a risk factor for adverse pregnancy outcomes?The Journal of Maternal-Fetal & Neonatal Medicine, 2012
- Asymptomatic Bacteriuria and Antibacterial Susceptibility Patterns in an Obstetric PopulationISRN Obstetrics and Gynecology, 2011
- Infection-related stillbirthsThe Lancet, 2010
- Asymptomatic Bacteriuria in Pregestational Diabetic Pregnancies and the Role of Group B StreptococcusAmerican Journal of Perinatology, 2009
- Asymptomatic bacteriuria during pregnancyThe Journal of Maternal-Fetal & Neonatal Medicine, 2009
- Institution of universal screening for Group B streptococcus (GBS) from a risk management protocol results in reduction of early‐onset GBS disease in a tertiary obstetric unitAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2007
- Asymptomatic bacteriuria in pregnancyBest Practice & Research Clinical Obstetrics & Gynaecology, 2007
- Chorioamnionitis and fetal response in stillbirthAmerican Journal of Obstetrics and Gynecology, 2007